ARTICLE | Clinical News
NNZ-2566: Phase Ib data
November 12, 2007 8:00 AM UTC
Neuren Pharmaceuticals Ltd. (ASX:NEU), Auckland, New Zealand Product: NNZ-2566 Business: Inflammation Molecular target: Not available Description: Small molecule analog of glycine-proline-glutamate, ...